On day 63, HIP CAR T cells showed significantly higher CAR+ cell numbers in the bone marrow and spleen and more effectively reduced CD19+ cancer cells in the bone marrow (Fig. 4e–g; Supplementary Fig. 6). The gene discussed is CD19; the disease is cancer.